Metastasis Suppressor Genes

  • Jean-Claude Marshall
  • Silvin Bakalian
  • Claudia Maria de Oliveira Martins
Chapter

Abstract

Below is a list of the most extensively studied MSGs, describing their initial characterization as well as what possible mechanism has been characterized for each .

Keywords

Metastasis Suppressor Metastasis Suppressor Gene Nm23 Expression KISS1 Expression BRMS1 Expression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bakalian S et al (2007) Expression of nm23-H1 in uveal melanoma. Melanoma Res 17(5):284–290PubMedCrossRefGoogle Scholar
  2. Bandyopadhyay S et al (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63(8):1731–1736PubMedGoogle Scholar
  3. Bandyopadhyay S et al (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23(33):5675–5681PubMedCrossRefGoogle Scholar
  4. Boissan M et al (2005) Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst 97(11):836–845PubMedCrossRefGoogle Scholar
  5. Cacace AM et al (1999) Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Mol Cell Biol 19(1):229–240PubMedGoogle Scholar
  6. Caligo MA et al (1994) A low NM23.H1 gene expression identifying high malignancy human melanomas. Melanoma Res 4(3):179–184PubMedCrossRefGoogle Scholar
  7. Chekmareva MA et al (1998) Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res 58(21):4963–4969PubMedGoogle Scholar
  8. Dhar DK et al (2004) Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer 111(6):868–872PubMedCrossRefGoogle Scholar
  9. Dong JT et al (1995) KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268(5212):884–886PubMedCrossRefGoogle Scholar
  10. Ferrari D et al (2007) Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma. J Cutan Pathol 34(9):705–712PubMedCrossRefGoogle Scholar
  11. Freije JM et al (1997) Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem 272(9):5525–5532PubMedCrossRefGoogle Scholar
  12. Fu Z et al (2003) Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95(12):878–889PubMedCrossRefGoogle Scholar
  13. Fu Z et al (2006) Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66(3):248–256PubMedCrossRefGoogle Scholar
  14. Goldberg SF et al (1999) Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate. Clin Exp Metastasis 17(7):601–607PubMedCrossRefGoogle Scholar
  15. Guan RJ et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60(3):749–755PubMedGoogle Scholar
  16. Hartsough MT, Steeg PS (2000) Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 32(3):301–308PubMedCrossRefGoogle Scholar
  17. Hartsough MT et al (2002) Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 277(35):32389–32399PubMedCrossRefGoogle Scholar
  18. Heimann R, Ferguson DJ, Hellman S (1998) The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer. Cancer Res 58(13):2766–2771PubMedGoogle Scholar
  19. Ichikawa T et al (1992) Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 52(12):3486–3490PubMedGoogle Scholar
  20. Ikeguchi M, Yamaguchi K, Kaibara N (2004) Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res 10(4):1379–1383PubMedCrossRefGoogle Scholar
  21. Kim HL et al (2001) Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res 61(7):2833–2837PubMedGoogle Scholar
  22. Klysik J et al (2008) Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 20(1):1–9PubMedCrossRefGoogle Scholar
  23. Kovacevic Z, Richardson DR (2006) The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27(12):2355–2366PubMedCrossRefGoogle Scholar
  24. Lacombe ML et al (2000) The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32(3):247–258PubMedCrossRefGoogle Scholar
  25. Lee JH, Welch DR (1997) Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57(12):2384–2387PubMedGoogle Scholar
  26. Lee JH et al (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88(23):1731–1737PubMedCrossRefGoogle Scholar
  27. Liu WM, Zhang XA (2006) KAI1/CD82, a tumor metastasis suppressor. Cancer Lett 240(2):183–194PubMedCrossRefGoogle Scholar
  28. Liu YN et al (2005) Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 24(56):8277–8290PubMedCrossRefGoogle Scholar
  29. Malik FA, Sanders AJ, Jiang WG (2009) KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis. Histol Histopathol 24(4):519–30PubMedGoogle Scholar
  30. Meehan WJ, Welch DR (2003) Breast cancer metastasis suppressor 1: update. Clin Exp Metastasis 20(1):45–50PubMedCrossRefGoogle Scholar
  31. Metge BJ et al (2010) Elevated Osteopontin Levels in Metastatic Melanoma Correlate with Epigenetic Silencing of Breast Cancer Metastasis Suppressor 1. Oncology 78(1):75–86PubMedCrossRefGoogle Scholar
  32. Miele ME et al (1996) Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Mol Carcinog 15(4):284–299PubMedCrossRefGoogle Scholar
  33. Morrison DK (2001) KSR: a MAPK scaffold of the Ras pathway? J Cell Sci 114(Pt 9):1609–1612PubMedGoogle Scholar
  34. Nash KT, Welch DR (2006) The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Front Biosci 11:647–659PubMedCrossRefGoogle Scholar
  35. Nash KT et al (2007) Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 99(4):309–321PubMedCrossRefGoogle Scholar
  36. Ohtaki T et al (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411(6837):613–617PubMedCrossRefGoogle Scholar
  37. Orsini MJ et al (2007) Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. J Med Chem 50(3):462–471PubMedCrossRefGoogle Scholar
  38. Pacifico MD et al (2005) nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up. Melanoma Res 15(5):435–440PubMedCrossRefGoogle Scholar
  39. Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C (2003) Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol 162(2):609–617PubMedCrossRefGoogle Scholar
  40. Seraj MJ et al (2000a) The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metastasis 18(6):519–525CrossRefGoogle Scholar
  41. Seraj MJ et al (2000b) Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 60(11):2764–2769Google Scholar
  42. Shirasaki F et al (2001) Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 61(20):7422–7425PubMedGoogle Scholar
  43. Stark AM et al (2005) Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131(3):191–198PubMedCrossRefGoogle Scholar
  44. Steeg PS (2003) Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3(1):55–63PubMedCrossRefGoogle Scholar
  45. Steeg PS (2004) Perspectives on classic article: metastasis suppressor genes. J Natl Cancer Inst 96(6):E4Google Scholar
  46. Steeg PS, Theodorescu D (2008) Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 5(4):206–219PubMedCrossRefGoogle Scholar
  47. Theodorescu D et al (2004) Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 10(11):3800–3806PubMedCrossRefGoogle Scholar
  48. Titus B et al (2005) Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. Cancer Res 65(16):7320–7327PubMedCrossRefGoogle Scholar
  49. van Belzen N et al (1997) A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77(1):85–92PubMedGoogle Scholar
  50. Vander Griend DJ et al (2005) Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res 65(23):10984–10991PubMedCrossRefGoogle Scholar
  51. Volle DJ et al (1999) Phosphorylation of the kinase suppressor of ras by associated kinases. Biochemistry 38(16):5130–5137PubMedCrossRefGoogle Scholar
  52. Wagner PD, Steeg PS, Vu ND (1997) Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci U S A 94(17):9000–9005PubMedCrossRefGoogle Scholar
  53. Whitmarsh AJ, Davis RJ (2007) Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 26(22):3172–3184PubMedCrossRefGoogle Scholar
  54. Wu Y et al (2007) Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene 26(5):765–773PubMedCrossRefGoogle Scholar
  55. Yamada SD et al (2002) Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res 62(22):6717–6723PubMedGoogle Scholar
  56. Yoshida BA et al (1999) Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res 59(21):5483–5487PubMedGoogle Scholar
  57. Yoshida S et al (2001) The c-Jun NH2-terminal kinase3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumors. J Hum Genet 46(4):182–187PubMedCrossRefGoogle Scholar
  58. Zhu S et al (2005) A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration. Chem Biol 12(9):981–991PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Jean-Claude Marshall
    • 1
  • Silvin Bakalian
    • 2
  • Claudia Maria de Oliveira Martins
    • 2
  1. 1.National Cancer InstituteBethesdaUSA
  2. 2.Henry C. Witelson Ocular Pathology LaboratoryMcGill UniversityMontrealCanada

Personalised recommendations